Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study

S Gerli, H Gholami, C Manna, A S Di Frega, C Vitiello, V Unfer, S Gerli, H Gholami, C Manna, A S Di Frega, C Vitiello, V Unfer

Abstract

Objective: To compare the effectiveness of clomiphene citrate used alone and in combination with ethinyl E2 for the induction of ovulation in patients undergoing IUI.

Design: Randomized, double-blind study.

Setting: Four infertility treatment centers.

Patient(s): Women aged 25-35 years with infertility of at least 2 years' duration and oligomenorrhea or amenorrhea associated with a positive menstrual response to an IM progesterone challenge.

Intervention(s): A total of 64 patients were randomized to treatment with CC (100 mg daily for 5 days) or CC (100 mg daily for 5 days) plus ethinyl E2 (0.05 mg daily for 5 days).

Main outcome measure(s): The uterine artery pulsatility index, number of preovulatory follicles, endometrial thickness, and pregnancy rate.

Result(s): Both treatment regimens increased FSH, LH, and 17beta-E2 levels, with no statistically significant differences. There was a statistically significant difference in endometrial thickness between the two treatment groups. No statistically significant differences were noted in pulsatility index values or in the number of preovulatory follicles.

Conclusion(s): Ethinyl E2 can reverse the deleterious effects of CC on endometrial thickness, which may contribute to higher pregnancy rates.

Source: PubMed

3
Předplatit